Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Scientific Reports|April 16, 2022
Deep learning model for tongue cancer diagnosis using endoscopic imagesJaesung Heo, June Hyuck Lim, Hye Ran Lee, et al.Iscience|October 7, 2025
Multiregional single-cell transcriptomics reveals an association between partial EMT and immunosuppressive states in oral squamous cell carcinomaSeunghoon Kim, Hyun Jung Kee, Dahee Kim, et al.Advanced Materials (Deerfield Beach, Fla.)|August 25, 2021
Cell-Membrane-Derived Nanoparticles with Notch-1 Suppressor Delivery Promote Hypoxic Cell-Cell Packing and Inhibit Angiogenesis Acting as a Two-Edged SwordHye-Seon Kim, Young Min Shin, Seyong Chung, et al.Cell Reports. Medicine|October 4, 2025
4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapyJunha Cha, Chang Gon Kim, Nam Suk Sim, et al.Journal of Medicinal Chemistry|October 18, 2021
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal InfectionJi Won Choi, Kyung-Tae Lee, Siwon Kim, et al.JCO Oncology Practice|August 25, 2022
Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer CenterEun Hee Jung, Si Won Lee, Yu Jung Kim, et al.Hepatology Communications|March 2, 2022
Global and regional long-term survival following resection for HCC in the recent decade: A meta-analysis of 110 studiesRosyli F Reveron-Thornton, Margaret L P Teng, Eunice Yewon Lee, et al.Advanced Materials (Deerfield Beach, Fla.)|December 24, 2024
Ligand Inter-Relation Analysis Via Graph Theory Predicts Macrophage ResponseNayeon Kang, Jangsun Hwang, Daun Jeong, et al.Nature Communications|December 23, 2024
Modularity-based mathematical modeling of ligand inter-nanocluster connectivity for unraveling reversible stem cell regulationChowon Kim, Nayeon Kang, Sunhong Min, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell CarcinomaChang Gon Kim, Min Hee Hong, Dahee Kim, et al.Pageof 15